AMSTERDAM, Sept. 10, 2024 (GLOBE NEWSWIRE) — The latest report from the Access to Medicine Foundation takes a first-ever look at the critical issue...
Vous n'êtes pas connecté
- English
- Français
- عربي
- Español
- Deutsch
- Português
- русский язык
- Català
- Italiano
- Nederlands, Vlaams
- Norsk
- فارسی
- বাংলা
- اردو
- Azərbaycan dili
- Bahasa Indonesia
- Հայերեն
- Ελληνικά
- Bosanski jezik
- українська мова
- Íslenska
- Türkmen, Түркмен
- Türkçe
- Shqip
- Eesti keel
- magyar
- Қазақ тілі
- Kalaallisut ; kalaallit oqaasii
- Lietuvių kalba
- Latviešu valoda
- македонски јазик
- Монгол
- Bahasa Melayu ; بهاس ملايو
- ဗမာစာ
- Slovenščina
- тоҷикӣ ; toğikī ; تاجیکی
- ไทย
- O'zbek ; Ўзбек ; أۇزبېك
- Tiếng Việt
- ភាសាខ្មែរ
- རྫོང་ཁ
- Soomaaliga ; af Soomaali
Maroc - NEWS.MEDICAL.NET - A la Une - 12/Sep 18:33
Pharma companies' strategies for reaching poorer countries remain unclear
Pharmaceutical companies must prioritize efforts to reach patients in underserved parts of the world with medicines such as insulin for diabetics and, crucially, measure the effectiveness of these efforts, says Jayasree Iyer, CEO of the Access to Medicine Foundation.
Articles similaires
A new report from the Access to Medicine Foundation reveals how patient-focused pharma companies’ access efforts are
menafocus.qa - 10/Sep 12:10
AMSTERDAM, Sept. 10, 2024 (GLOBE NEWSWIRE) — The latest report from the Access to Medicine Foundation takes a first-ever look at the critical issue...
A new report from the Access to Medicine Foundation reveals how patient-focused pharma companies’ access efforts are
pressarabia.qa - 10/Sep 12:10
AMSTERDAM, Sept. 10, 2024 (GLOBE NEWSWIRE) — The latest report from the Access to Medicine Foundation takes a first-ever look at the critical issue...
A new report from the Access to Medicine Foundation reveals how patient-focused pharma companies’ access efforts are
pressarabia.qa - 10/Sep 12:10
AMSTERDAM, Sept. 10, 2024 (GLOBE NEWSWIRE) — The latest report from the Access to Medicine Foundation takes a first-ever look at the critical issue...
A new report from the Access to Medicine Foundation reveals how patient-focused pharma companies’ access efforts are
qatarnewswire.qa - 10/Sep 12:10
AMSTERDAM, Sept. 10, 2024 (GLOBE NEWSWIRE) — The latest report from the Access to Medicine Foundation takes a first-ever look at the critical issue...
A new report from the Access to Medicine Foundation reveals how patient-focused pharma companies’ access efforts are
qatarnewswire.qa - 10/Sep 12:10
AMSTERDAM, Sept. 10, 2024 (GLOBE NEWSWIRE) — The latest report from the Access to Medicine Foundation takes a first-ever look at the critical issue...
A new report from the Access to Medicine Foundation reveals how patient-focused pharma companies’ access efforts are
qatarnewswire.qa - 10/Sep 12:10
AMSTERDAM, Sept. 10, 2024 (GLOBE NEWSWIRE) — The latest report from the Access to Medicine Foundation takes a first-ever look at the critical issue...
A new report from the Access to Medicine Foundation reveals how patient-focused pharma companies’ access efforts are
qatarnewswire.qa - 10/Sep 12:10
AMSTERDAM, Sept. 10, 2024 (GLOBE NEWSWIRE) — The latest report from the Access to Medicine Foundation takes a first-ever look at the critical issue...
A new report from the Access to Medicine Foundation reveals how patient-focused pharma companies’ access efforts are
qatarnewswire.qa - 10/Sep 12:10
AMSTERDAM, Sept. 10, 2024 (GLOBE NEWSWIRE) — The latest report from the Access to Medicine Foundation takes a first-ever look at the critical issue...
A new report from the Access to Medicine Foundation reveals how patient-focused pharma companies’ access efforts are
qatarnewswire.qa - 10/Sep 12:10
AMSTERDAM, Sept. 10, 2024 (GLOBE NEWSWIRE) — The latest report from the Access to Medicine Foundation takes a first-ever look at the critical issue...
Les derniers communiqués
-
Aucun élément